Retatrutide is investigated in laboratory and clinical research for its simultaneous interaction with three receptors involved in metabolic signalling: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor
Research peptide pages are informational and are not medical advice, prescription guidance, dosing instructions, treatment recommendations, or instructions for human consumption
This is because NNMTi improves fat metabolism to assist weight loss, alleviates intestinal inflammation, and reduces gastrointestinal adverse reactions.These combined intervention studies provide novel strategies for clinical obesity management and expand the application scope of NNMTi
Dual Agonists: Tirzepatide Tirzepatide is a step above semaglutide
The 5R Framework for Gut Health Restoration: Remove: Eliminate inflammatory foods and toxins